| 10098667
|
Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
1999 |
Venkatraman S;Kong J;Nimkar S;Wang QM;Aube J;Hanzlik RP |
View
More |
| 10197964
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10197965
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Webber SE;Marakovits JT;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Ford CE;Burke BJ;Rejto PA;Hendrickson TF;Tuntland T;Brown EL;Meador JW 3rd;Ferre RA;Harr JE;Kosa MB;Worland ST |
View
More |
| 10224078
|
Identification and characterization of human rhinovirus-14 3C protease deamidation isoform. |
J Biol Chem |
1999 |
Cox GA;Johnson RB;Cook JA;Wakulchik M;Johnson MG;Villarreal EC;Wang QM |
View
More |
| 10353638
|
Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides. |
Bioorg Med Chem |
1999 |
Dragovich PS;Zhou R;Skalitzky DJ;Fuhrman SA;Patick AK;Ford CE;Meador JW 3rd;Worland ST |
View
More |
| 10396129
|
Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. |
Prog Drug Res |
1999 |
Wang QM |
View
More |
| 10465543
|
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. |
Bioorg Med Chem Lett |
1999 |
Dragovich PS;Webber SE;Prins TJ;Zhou R;Marakovits JT;Tikhe JG;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Brown EL;Binford SL;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10500114
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. |
Proc Natl Acad Sci U S A |
1999 |
Matthews DA;Dragovich PS;Webber SE;Fuhrman SA;Patick AK;Zalman LS;Hendrickson TF;Love RA;Prins TJ;Marakovits JT;Zhou R;Tikhe J;Ford CE;Meador JW;Ferre RA;Brown EL;Binford SL;Brothers MA;DeLisle DM;Worland ST |
View
More |
| 10507325
|
The structures of picornaviral proteinases. |
Virus Res |
1999 |
Seipelt J;Guarne A;Bergmann E;James M;Sommergruber W;Fita I;Skern T |
View
More |
| 10508022
|
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
1999 |
Patick AK;Binford SL;Brothers MA;Jackson RL;Ford CE;Diem MD;Maldonado F;Dragovich PS;Zhou R;Prins TJ;Fuhrman SA;Meador JW;Zalman LS;Matthews DA;Worland ST |
View
More |
| 10636240
|
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2000 |
Dragovich PS;Zhou R;Webber SE;Prins TJ;Kwok AK;Okano K;Fuhrman SA;Zalman LS;Maldonado FC;Brown EL;Meador JW 3rd;Patick AK;Ford CE;Brothers MA;Binford SL;Matthews DA;Ferre RA;Worland ST |
View
More |
| 10770757
|
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2000 |
Zalman LS;Brothers MA;Dragovich PS;Zhou R;Prins TJ;Worland ST;Patick AK |
View
More |
| 10794684
|
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. |
J Med Chem |
2000 |
Reich SH;Johnson T;Wallace MB;Kephart SE;Fuhrman SA;Worland ST;Matthews DA;Hendrickson TF;Chan F;Meador J 3rd;Ferre RA;Brown EL;DeLisle DM;Patick AK;Binford SL;Ford CE |
View
More |
| 10950388
|
Antiviral therapy for enteroviruses and rhinoviruses. |
Antivir Chem Chemother |
2000 |
Rotbart HA |
View
More |
| 10999479
|
S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2000 |
Xian M;Wang QM;Chen X;Wang K;Wang PG |
View
More |
| 11118371
|
Complete nucleotide sequence of the chiba virus genome and functional expression of the 3C-like protease in Escherichia coli. |
Virology |
2000 |
Someya Y;Takeda N;Miyamura T |
View
More |
| 11162821
|
Activation of human rhinovirus-14 3C protease. |
Virology |
2001 |
Wang QM;Johnson RB |
View
More |
| 11166856
|
The treatment of rhinovirus infections: progress and potential. |
Antiviral Res |
2001 |
Turner RB |
View
More |
| 11274152
|
Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. |
J Biol Chem |
2001 |
Bushell M;Wood W;Carpenter G;Pain VM;Morley SJ;Clemens MJ |
View
More |
| 11302940
|
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. |
Drug Metab Dispos |
2001 |
Zhang KE;Hee B;Lee CA;Liang B;Potts BC |
View
More |
| 11378491
|
Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces. |
J Clin Virol |
2001 |
Ostroff R;Ettinger A;La H;Rihanek M;Zalman L;Meador J 3rd;Patick AK;Worland S;Polisky B |
View
More |
| 11414203
|
MBP fusion protein with a viral protease cleavage site: one-step cleavage/purification of insoluble proteins. |
Biotechniques |
2001 |
Alexandrov A;Dutta K;Pascal SM |
View
More |
| 11548209
|
Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. |
Prog Drug Res |
2001 |
Wang QM |
View
More |
| 11591501
|
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2001 |
Webber SE;Marakovits JT;Dragovich PS;Prins TJ;Zhou R;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Srinivasan B;Moran T;Ford CE;Brothers MA;Harr JE;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 11720861
|
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. |
Bioorg Med Chem Lett |
2001 |
Singh SB;Graham PL;Reamer RA;Cordingley MG |
View
More |
| 11858991
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics. |
Bioorg Med Chem Lett |
2002 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Hou X;Meador JW;Ferre RA;Worland ST |
View
More |
| 11900346
|
Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing. |
Antivir Chem Chemother |
2001 |
Murray MA;Janc JW;Venkatraman S;Babe LM |
View
More |
| 11911365
|
Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C. |
RNA |
2002 |
Zell R;Sidigi K;Bucci E;Stelzner A;Gorlach M |
View
More |
| 11931615
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. |
J Med Chem |
2002 |
Dragovich PS;Prins TJ;Zhou R;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Tuntland T;Lee CA;Patick AK;Matthews DA;Hendrickson TF;Kosa MB;Liu B;Batugo MR;Gleeson JP;Sakata SK;Chen L;Guzman MC;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 11985469
|
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease. |
J Med Chem |
2002 |
Johnson TO;Hua Y;Luu HT;Brown EL;Chan F;Chu SS;Dragovich PS;Eastman BW;Ferre RA;Fuhrman SA;Hendrickson TF;Maldonado FC;Matthews DA;Meador JW 3rd;Patick AK;Reich SH;Skalitzky DJ;Worland ST;Yang M;Zalman LS |
View
More |
| 12525179
|
The unusual catalytic triad of poliovirus protease 3C. |
Biochemistry |
2003 |
Sarkany Z;Polgar L |
View
More |
| 12766405
|
Backbone 1H, 15N and 13C assignments for the human rhinovirus 3C protease (serotype 14). |
J Biomol NMR |
2003 |
Bjorndahl TC;Monzavi H;Wishart DS |
View
More |
| 12921996
|
Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription. |
Virus Res |
2003 |
Aminev AG;Amineva SP;Palmenberg AC |
View
More |
| 14505664
|
Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2003 |
Chen SH;Lamar J;Victor F;Snyder N;Johnson R;Heinz BA;Wakulchik M;Wang QM |
View
More |
| 14521419
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. |
J Med Chem |
2003 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Hua Y;Luu HT;Sakata SK;Brown EL;Maldonado FC;Tuntland T;Lee CA;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Wu EY;Guo M;Borer BC;Nayyar NK;Moran T;Chen L;Rejto PA;Rose PW;Guzman MC;Dovalsantos EZ;Lee S;McGee K;Mohajeri M;Liese A;Tao J;Kosa MB;Liu B;Batugo MR;Gleeson JP;Wu ZP;Liu J;Meador JW 3rd;Ferre RA |
View
More |
| 14605258
|
Rhinovirus 16 3C protease induces interleukin-8 and granulocyte-macrophage colony-stimulating factor expression in human bronchial epithelial cells. |
Pediatr Res |
2004 |
Funkhouser AW;Kang JA;Tan A;Li J;Zhou L;Abe MK;Solway J;Hershenson MB |
View
More |
| 15168795
|
An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents. |
Antiviral Res |
2004 |
Ettinger A;Ostroff R;Rhihanek M;Dragovich PS;Zalman LS;Patick AK;Prins TJ;Fuhrman SA;Brown EL;Worland ST;Polisky B |
View
More |
| 15448360
|
Rhinovirus 3C protease precursors 3CD and 3CD\' localize to the nuclei of infected cells. |
J Gen Virol |
2004 |
Amineva SP;Aminev AG;Palmenberg AC;Gern JE |
View
More |
| 15673742
|
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2005 |
Binford SL;Maldonado F;Brothers MA;Weady PT;Zalman LS;Meador JW 3rd;Matthews DA;Patick AK |
View
More |
| 15814817
|
A novel cGUUAg tetraloop structure with a conserved yYNMGg-type backbone conformation from cloverleaf 1 of bovine enterovirus 1 RNA. |
Nucleic Acids Res |
2005 |
Ihle Y;Ohlenschlager O;Hafner S;Duchardt E;Zacharias M;Seitz S;Zell R;Ramachandran R;Gorlach M |
View
More |
| 15917520
|
In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
2005 |
Patick AK;Brothers MA;Maldonado F;Binford S;Maldonado O;Fuhrman S;Petersen A;Smith GJ 3rd;Zalman LS;Burns-Naas LA;Tran JQ |
View
More |
| 16279553
|
[Rhinovirus diseases: pathogenesis, diagnostics and treatment]. |
Zh Mikrobiol Epidemiol Immunobiol |
2005 |
Faizuloev EB;Nikonova AA;Zverev VV |
View
More |
| 1653490
|
Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli. |
Virology |
1991 |
Aschauer B;Werner G;McCray J;Rosenwirth B;Bachmayer H |
View
More |
| 1654789
|
Development of synthetic peptide substrates for the poliovirus 3C proteinase. |
Arch Biochem Biophys |
1991 |
Weidner JR;Dunn BM |
View
More |
| 1658106
|
Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay. |
J Biochem Biophys Methods |
1991 |
Hopkins JL;Betageri R;Cohen KA;Emmanuel MJ;Joseph CR;Bax PM;Pallai PV;Skoog MT |
View
More |
| 17267501
|
MDA-5 is cleaved in poliovirus-infected cells. |
J Virol |
2007 |
Barral PM;Morrison JM;Drahos J;Gupta P;Sarkar D;Fisher PB;Racaniello VR |
View
More |
| 17305557
|
Human rhinovirus 3C protease as a potential target for the development of antiviral agents. |
Curr Protein Pept Sci |
2007 |
Wanga QM;Chen SH |
View
More |
| 17374764
|
PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. |
J Gen Virol |
2007 |
Lanke K;Krenn BM;Melchers WJG;Seipelt J;van Kuppeveld FJM |
View
More |
| 17485072
|
Development of potent inhibitors of the coxsackievirus 3C protease. |
Biochem Biophys Res Commun |
2007 |
Lee ES;Lee WG;Yun SH;Rho SH;Im I;Yang ST;Sellamuthu S;Lee YJ;Kwon SJ;Park OK;Jeon ES;Park WJ;Kim YC |
View
More |
| 17908951
|
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
2007 |
Binford SL;Weady PT;Maldonado F;Brothers MA;Matthews DA;Patick AK |
View
More |
| 17944485
|
NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison. |
Biochemistry |
2007 |
Bjorndahl TC;Andrew LC;Semenchenko V;Wishart DS |
View
More |
| 18248816
|
New anti-viral drugs for the treatment of the common cold. |
Bioorg Med Chem |
2008 |
Maugeri C;Alisi MA;Apicella C;Cellai L;Dragone P;Fioravanzo E;Florio S;Furlotti G;Mangano G;Ombrato R;Luisi R;Pompei R;Rincicotti V;Russo V;Vitiello M;Cazzolla N |
View
More |
| 18572216
|
Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. |
Virology |
2008 |
de Breyne S;Bonderoff JM;Chumakov KM;Lloyd RE;Hellen CU |
View
More |
| 18583140
|
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. |
Bioorg Med Chem |
2008 |
Kuo CJ;Shie JJ;Fang JM;Yen GR;Hsu JT;Liu HG;Tseng SN;Chang SC;Lee CY;Shih SR;Liang PH |
View
More |
| 19048198
|
Viral protease inhibitors. |
Handb Exp Pharmacol |
2009 |
Anderson J;Schiffer C;Lee SK;Swanstrom R |
View
More |
| 19268541
|
A picornaviral loop-to-loop replication complex. |
J Struct Biol |
2009 |
Claridge JK;Headey SJ;Chow JY;Schwalbe M;Edwards PJ;Jeffries CM;Venugopal H;Trewhella J;Pascal SM |
View
More |
| 19333433
|
Over-expression, rapid preparation and some properties of c-terminal BARc region in PICK1. |
Int J Mol Sci |
2009 |
Xiao H;Shi Y;Yuan J;Huang Y;Wang J |
View
More |
| 19403669
|
Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. |
J Virol |
2009 |
Ghildyal R;Jordan B;Li D;Dagher H;Bardin PG;Gern JE;Jans DA |
View
More |
| 19457455
|
Robust production of a peptide library using methodological synchronization. |
Protein Expr Purif |
2009 |
Huber KL;Olson KD;Hardy JA |
View
More |
| 19464175
|
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2009 |
Im I;Lee ES;Choi SJ;Lee JY;Kim YC |
View
More |
| 19628239
|
RIG-I is cleaved during picornavirus infection. |
Virology |
2009 |
Barral PM;Sarkar D;Fisher PB;Racaniello VR |
View
More |
| 20021285
|
Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors. |
Expert Opin Ther Pat |
2010 |
Wang HM;Liang PH |
View
More |
| 20066739
|
Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. |
World J Gastroenterol |
2010 |
Zhang XN;Song ZG;Jiang T;Shi BS;Hu YW;Yuan ZH |
View
More |
| 21183345
|
Non-covalent inhibitors of rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2011 |
Baxter A;Chambers M;Edfeldt F;Edman K;Freeman A;Johansson C;King S;Morley A;Petersen J;Rawlins P;Spadola L;Thong B;Van de Poel H;Williams N |
View
More |
| 21543871
|
Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor. |
Acta Crystallogr Sect F Struct Biol Cryst Commun |
2011 |
Amacher JF;Cushing PR;Weiner JA;Madden DR |
View
More |
| 21605680
|
Production and single-step purification of EGFP and a biotinylated version of the Human Rhinovirus 14 3C protease. |
Protein Expr Purif |
2011 |
Youell J;Fordham D;Firman K |
View
More |
| 2160953
|
Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. |
J Biol Chem |
1990 |
Cordingley MG;Callahan PL;Sardana VV;Garsky VM;Colonno RJ |
View
More |
| 21795339
|
Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. |
J Virol |
2011 |
Lu G;Qi J;Chen Z;Xu X;Gao F;Lin D;Qian W;Liu H;Jiang H;Yan J;Gao GF |
View
More |
| 21813612
|
Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. |
J Virol |
2011 |
Wang J;Fan T;Yao X;Wu Z;Guo L;Lei X;Wang J;Wang M;Jin Q;Cui S |
View
More |
| 21835784
|
Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93. |
J Virol |
2011 |
Costenaro L;Kaczmarska Z;Arnan C;Janowski R;Coutard B;Sola M;Gorbalenya AE;Norder H;Canard B;Coll M |
View
More |
| 21936817
|
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery. |
Biochem Soc Trans |
2011 |
Ramajayam R;Tan KP;Liang PH |
View
More |
| 22763202
|
A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors. |
Bioorg Med Chem Lett |
2012 |
Schunemann K;Connelly S;Kowalczyk R;Sperry J;Wilson IA;Fraser JD;Brimble MA |
View
More |
| 23131833
|
Picornavirus modification of a host mRNA decay protein. |
mBio |
2012 |
Rozovics JM;Chase AJ;Cathcart AL;Chou W;Gershon PD;Palusa S;Wilusz J;Semler BL |
View
More |
| 23255796
|
Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections. |
J Virol |
2013 |
Fitzgerald KD;Chase AJ;Cathcart AL;Tran GP;Semler BL |
View
More |
| 23300834
|
Express your LOV: an engineered flavoprotein as a reporter for protein expression and purification. |
PLoS One |
2012 |
Gawthorne JA;Reddick LE;Akpunarlieva SN;Beckham KS;Christie JM;Alto NM;Gabrielsen M;Roe AJ |
View
More |
| 23388726
|
3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. |
J Virol |
2013 |
Tan J;George S;Kusov Y;Perbandt M;Anemuller S;Mesters JR;Norder H;Coutard B;Lacroix C;Leyssen P;Neyts J;Hilgenfeld R |
View
More |
| 23395976
|
Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases. |
Anal Biochem |
2013 |
Raran-Kurussi S;Tozser J;Cherry S;Tropea JE;Waugh DS |
View
More |
| 23410102
|
A new method to customize protein expression vectors for fast, efficient and background free parallel cloning. |
BMC Biotechnol |
2013 |
Scholz J;Besir H;Strasser C;Suppmann S |
View
More |
| 23633597
|
Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. |
Acta Crystallogr D Biol Crystallogr |
2013 |
Wu C;Cai Q;Chen C;Li N;Peng X;Cai Y;Yin K;Chen X;Wang X;Zhang R;Liu L;Chen S;Li J;Lin T |
View
More |
| 23903828
|
Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. |
J Virol |
2013 |
Cathcart AL;Rozovics JM;Semler BL |
View
More |
| 23951130
|
Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. |
PLoS One |
2013 |
Walker EJ;Younessi P;Fulcher AJ;McCuaig R;Thomas BJ;Bardin PG;Jans DA;Ghildyal R |
View
More |
| 24346589
|
Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone). |
Org Biomol Chem |
2014 |
Schunemann K;Furkert DP;Choi EC;Connelly S;Fraser JD;Sperry J;Brimble MA |
View
More |
| 24649897
|
A new fusion protein platform for quantitatively measuring activity of multiple proteases. |
Microb Cell Fact |
2014 |
Zhou C;Yan Y;Fang J;Cheng B;Fan J |
View
More |
| 24727155
|
A novel self-cleavage system for production of soluble recombinant protein in Escherichia coli. |
Protein Expr Purif |
2014 |
Feng Y;Xu Q;Yang T;Sun E;Li J;Shi D;Wu D |
View
More |
| 25259514
|
Synthesis and evaluation of 9-deoxy analogues of (-)-thysanone, an inhibitor of HRV 3C protease. |
Eur J Med Chem |
2014 |
Young Jeong J;Sperry J;Taylor JA;Brimble MA |
View
More |
| 25261311
|
Proteases of human rhinovirus: role in infection. |
Methods Mol Biol |
2015 |
Jensen LM;Walker EJ;Jans DA;Ghildyal R |
View
More |
| 25261312
|
A protocol to express and isolate HRV16 3C protease for use in protease assays. |
Methods Mol Biol |
2015 |
Jensen LM;Walker EJ;Ghildyal R |
View
More |
| 25350699
|
Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. |
Bioconjug Chem |
2014 |
Stefan N;Zimmermann M;Simon M;Zangemeister-Wittke U;Pluckthun A |
View
More |
| 2546760
|
The expression and purification of human rhinovirus protease 3C. |
Eur J Biochem |
1989 |
Knott JA;Orr DC;Montgomery DS;Sullivan CA;Weston A |
View
More |
| 2555433
|
Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. |
J Gen Virol |
1989 |
Orr DC;Long AC;Kay J;Dunn BM;Cameron JM |
View
More |
| 2555540
|
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. |
J Virol |
1989 |
Cordingley MG;Register RB;Callahan PL;Garsky VM;Colonno RJ |
View
More |
| 2556299
|
A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase. |
FEBS Lett |
1989 |
Long AC;Orr DC;Cameron JM;Dunn BM;Kay J |
View
More |
| 25792507
|
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. |
J Enzyme Inhib Med Chem |
2016 |
Ang MJ;Lau QY;Ng FM;Then SW;Poulsen A;Cheong YK;Ngoh ZX;Tan YW;Peng J;Keller TH;Hill J;Chu JJ;Chia CS |
View
More |
| 27093053
|
Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production. |
PLoS One |
2016 |
Ullah R;Shah MA;Tufail S;Ismat F;Imran M;Iqbal M;Mirza O;Rhaman M |
View
More |
| 27105777
|
A dual protease approach for expression and affinity purification of recombinant proteins. |
Anal Biochem |
2016 |
Raran-Kurussi S;Waugh DS |
View
More |
| 27265257
|
Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2016 |
Kawatkar SP;Gagnon M;Hoesch V;Tiong-Yip C;Johnson K;Ek M;Nilsson E;Lister T;Olsson L;Patel J;Yu Q |
View
More |
| 27645381
|
Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease. |
Sci Rep |
2016 |
Tan YW;Ang MJ;Lau QY;Poulsen A;Ng FM;Then SW;Peng J;Hill J;Hong WJ;Chia CS;Chu JJ |
View
More |
| 27681132
|
Rhinovirus 16 2A Protease Affects Nuclear Localization of 3CD during Infection. |
J Virol |
2016 |
Walker E;Jensen L;Croft S;Wei K;Fulcher AJ;Jans DA;Ghildyal R |
View
More |
| 28217559
|
A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity. |
Front Cell Infect Microbiol |
2017 |
Li B;Yue Y;Zhang Y;Yuan Z;Li P;Song N;Lin W;Liu Y;Gu L;Meng H |
View
More |
| 28778471
|
Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2017 |
Zhang Q;Cao R;Liu A;Lei S;Li Y;Yang J;Li S;Xiao J |
View
More |
| 28801725
|
Optimization of Soluble Expression and Purification of Recombinant Human Rhinovirus Type-14 3C Protease Using Statistically Designed Experiments: Isolation and Characterization of the Enzyme. |
Mol Biotechnol |
2017 |
Antoniou G;Papakyriacou I;Papaneophytou C |
View
More |
| 29371673
|
Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation. |
Sci Rep |
2018 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 29433930
|
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2018 |
Namoto K;Sirockin F;Sellner H;Wiesmann C;Villard F;Moreau RJ;Valeur E;Paulding SC;Schleeger S;Schipp K;Loup J;Andrews L;Swale R;Robinson M;Farady CJ |
View
More |
| 29449668
|
Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. |
Cell Death Dis |
2018 |
Lotzerich M;Roulin PS;Boucke K;Witte R;Georgiev O;Greber UF |
View
More |
| 29530860
|
Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro. |
Antimicrob Agents Chemother |
2018 |
Kitano M;Hosmillo M;Emmott E;Lu J;Goodfellow I |
View
More |
| 29866517
|
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro. |
Bioorg Med Chem Lett |
2018 |
Jung E;Lee JY;Kim HJ;Ryu CK;Lee KI;Kim M;Lee CK;Go YY |
View
More |
| 30118570
|
Building and Breaking Bonds via a Compact S-Propargyl-Cysteine to Chemically Control Enzymes and Modify Proteins. |
Angew Chem Int Ed Engl |
2018 |
Liu J;Cheng R;Wu H;Li S;Wang PG;DeGrado WF;Rozovsky S;Wang L |
View
More |
| 30352199
|
Development of a homogeneous time-resolved fluorescence assay for detection of viral double-stranded RNA. |
Anal Biochem |
2019 |
Fujita M;Adachi K;Nagasawa M |
View
More |
| 30461192
|
Toward development of generic inhibitors against the 3C proteases of picornaviruses. |
FEBS J |
2019 |
Banerjee K;Bhat R;Rao VUB;Nain A;Rallapalli KL;Gangopadhyay S;Singh RP;Banerjee M;Jayaram B |
View
More |
| 30646829
|
Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. |
J Biomol Struct Dyn |
2020 |
Jain S;Amin SA;Adhikari N;Jha T;Gayen S |
View
More |
| 30686346
|
A simplified method to remove fusion tags from a xylanase of Bacillus sp. HBP8 with HRV 3C protease. |
Enzyme Microb Technol |
2019 |
Xu H;Wang Q;Zhang Z;Yi L;Ma L;Zhai C |
View
More |
| 30802413
|
A General Guide for the Optimization of Enzyme Assay Conditions Using the Design of Experiments Approach. |
SLAS Discov |
2019 |
Onyeogaziri FC;Papaneophytou C |
View
More |
| 30844608
|
New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling. |
Eur J Med Chem |
2019 |
Kassem AF;Batran RZ;Abbas EMH;Elseginy SA;Shaheen MNF;Elmahdy EM |
View
More |
| 30868206
|
Soluble expression of IGF1 fused to DsbA in SHuffle T7 strain: optimization of expression and purification by Box-Behnken design. |
Appl Microbiol Biotechnol |
2019 |
Emamipour N;Vossoughi M;Mahboudi F;Golkar M;Fard-Esfahani P |
View
More |
| 31117169
|
Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3. |
Molecules |
2019 |
Wagner HJ;Weber W |
View
More |
| 31612259
|
Using the IPTG-Inducible Pgrac212 Promoter for Overexpression of Human Rhinovirus 3C Protease Fusions in the Cytoplasm of Bacillus subtilis Cells. |
Curr Microbiol |
2019 |
Le VD;Phan TTP;Nguyen TM;Brunsveld L;Schumann W;Nguyen HD |
View
More |
| 31613083
|
Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms. |
ACS Chem Biol |
2020 |
Fan X;Li X;Zhou Y;Mei M;Liu P;Zhao J;Peng W;Jiang ZB;Yang S;Iverson BL;Zhang G;Yi L |
View
More |
| 32103448
|
Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design. |
Virol Sin |
2020 |
Yuan S;Fan K;Chen Z;Sun Y;Hou H;Zhu L |
View
More |
| 32467165
|
Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses. |
Proc Natl Acad Sci U S A |
2020 |
Meng B;Lan K;Xie J;Lerner RA;Wilson IA;Yang B |
View
More |
| 33093214
|
Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. |
Science |
2020 |
Robinson KS;Teo DET;Tan KS;Toh GA;Ong HH;Lim CK;Lay K;Au BV;Lew TS;Chu JJH;Chow VTK;Wang Y;Zhong FL;Reversade B |
View
More |
| 33166527
|
NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage. |
J Biotechnol |
2021 |
Abdelkader EH;Otting G |
View
More |
| 34077853
|
A CDR-based approach to generate covalent inhibitory antibody for human rhinovirus protease. |
Bioorg Med Chem |
2021 |
Cheng Y;Wu J;Han Y;Xu J;Da Y;Zhao Q;Guo G;Zhou Y;Chen Y;Liu J;Chen H;Jiang X;Cai X |
View
More |
| 34151629
|
High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease. |
SLAS Discov |
2021 |
Scholle MD;McLaughlin D;Gurard-Levin ZA |
View
More |
| 34626801
|
Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies. |
Protein Expr Purif |
2022 |
Cantrell MS;Wall JD;Pu X;Turner M;Woodbury L;Fujise K;McDougal OM;Warner LR |
View
More |
| 34960671
|
RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups. |
Viruses |
2021 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 35504537
|
EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication. |
Virol Sin |
2022 |
Zhou X;Tian L;Wang J;Zheng B;Zhang W |
View
More |
| 35597150
|
Specific anion effect on properties of HRV 3C protease. |
Biophys Chem |
2022 |
Dusekova E;Berta M;Sedlakova D;Reha D;Dzurillova V;Shaposhnikova A;Fadaei F;Tomkova M;Minofar B;Sedlak E |
View
More |
| 35642592
|
In vivo enzymatic digestion of HRV 3C protease cleavage sites-containing proteins produced in a silkworm-baculovirus expression system. |
Biosci Rep |
2022 |
Xu J;Nakanishi T;Kato T;Park EY |
View
More |
| 7515772
|
Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. |
Cell |
1994 |
Matthews DA;Smith WW;Ferre RA;Condon B;Budahazi G;Sisson W;Villafranca JE;Janson CA;McElroy HE;Gribskov CL;et al. |
View
More |
| 7645249
|
Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. |
Virology |
1995 |
Joachims M;Harris KS;Etchison D |
View
More |
| 7745714
|
Interaction between the 5\'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. |
J Virol |
1995 |
Xiang W;Harris KS;Alexander L;Wimmer E |
View
More |
| 7765405
|
A high capacity microbial screen for inhibitors of human rhinovirus protease 3C. |
Biotechnology (N Y) |
1994 |
McCall JO;Kadam S;Katz L |
View
More |
| 7782313
|
Sequence and structural determinants of the interaction between the 5\'-noncoding region of picornavirus RNA and rhinovirus protease 3C. |
J Biol Chem |
1995 |
Walker PA;Leong LE;Porter AG |
View
More |
| 7794931
|
Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. |
Biochemistry |
1995 |
Malcolm BA;Lowe C;Shechosky S;McKay RT;Yang CC;Shah VJ;Simon RJ;Vederas JC;Santi DV |
View
More |
| 8071130
|
Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen. |
J Antibiot (Tokyo) |
1994 |
Kadam S;Poddig J;Humphrey P;Karwowski J;Jackson M;Tennent S;Fung L;Hochlowski J;Rasmussen R;McAlpine J |
View
More |
| 8164744
|
Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. |
Nature |
1994 |
Allaire M;Chernaia MM;Malcolm BA;James MN |
View
More |
| 8245010
|
Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5\'-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. |
J Biol Chem |
1993 |
Leong LE;Walker PA;Porter AG |
View
More |
| 8320292
|
Structural and mechanistic aspects of 3C proteases from the Picornavirus family. |
J Chem Inf Comput Sci |
1993 |
Arad D;Kreisberg R;Shokhen M |
View
More |
| 8520469
|
The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds. |
Protein Sci |
1995 |
Malcolm BA |
View
More |
| 8535153
|
Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli. |
Protein Expr Purif |
1995 |
Birch GM;Black T;Malcolm SK;Lai MT;Zimmerman RE;Jaskunas SR |
View
More |
| 8787922
|
Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases. |
Antimicrob Agents Chemother |
1996 |
Heinz BA;Tang J;Labus JM;Chadwell FW;Kaldor SW;Hammond M |
View
More |
| 8972564
|
Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo. |
Virus Genes |
1996 |
Hall DJ;Palmenberg AC |
View
More |
| 8978838
|
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. |
J Med Chem |
1996 |
Webber SE;Tikhe J;Worland ST;Fuhrman SA;Hendrickson TF;Matthews DA;Love RA;Patick AK;Meador JW;Ferre RA;Brown EL;DeLisle DM;Ford CE;Binford SL |
View
More |
| 9328292
|
Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase. |
Arch Biochem Biophys |
1997 |
Davis GJ;Wang QM;Cox GA;Johnson RB;Wakulchik M;Dotson CA;Villarreal EC |
View
More |
| 9344409
|
A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. |
Anal Biochem |
1997 |
Wang QM;Johnson RB;Cox GA;Villarreal EC;Loncharich RJ |
View
More |
| 9651162
|
Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. |
J Med Chem |
1998 |
Kong JS;Venkatraman S;Furness K;Nimkar S;Shepherd TA;Wang QM;Aube J;Hanzlik RP |
View
More |
| 9667969
|
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. |
J Med Chem |
1998 |
Webber SE;Okano K;Little TL;Reich SH;Xin Y;Fuhrman SA;Matthews DA;Love RA;Hendrickson TF;Patick AK;Meador JW 3rd;Ferre RA;Brown EL;Ford CE;Binford SL;Worland ST |
View
More |
| 9667970
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Reich SH;Prins TJ;Marakovits JT;Littlefield ES;Zhou R;Tikhe J;Ford CE;Wallace MB;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;Harr JE;DeLisle DM;Worland ST |
View
More |
| 9667971
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Reich SH;Marakovits JT;Prins TJ;Zhou R;Tikhe J;Littlefield ES;Bleckman TM;Wallace MB;Little TL;Ford CE;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;DeLisle DM;Worland ST |
View
More |
| 9989947
|
Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. |
Arch Biochem Biophys |
1999 |
Kati WM;Sham HL;McCall JO;Montgomery DA;Wang GT;Rosenbrook W;Miesbauer L;Buko A;Norbeck DW |
View
More |
